Wisp Tirzepatide Review: Cost, a Verified Seal & a Real Pricing Gap (2026)

Wisp has a genuine LegitScript seal (#3454890) served from LegitScript's own CDN via a Next.js image proxy, matching its site-wide certification claim. Every fact here comes from the company's own published program.

A real gap between the advertised price and the drug cost

Worth flagging directly is the advertised "$99/month" tirzepatide figure is a consultation-and-care subscription, not the medication itself. Zepbound is filled at a pharmacy of your choice at its own separate cost, which Wisp does not publish — meaning the true all-in monthly cost is significantly higher than the headline number suggests.

What Wisp is

Wisp (hellowisp.com) is a US telehealth provider, whose weight-care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month. LegitScript certified, with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC).

What Wisp costs

The $99/month figure covers the consultation-and-care subscription only — brand-name Zepbound itself is a separate prescription filled at a pharmacy of your choosing, at that pharmacy's own price, which Wisp does not publish. The compounded sublingual semaglutide drops option runs $225/month, and Wisp itself candidly notes this format may be less effective than injection.

The brand-vs-compounded question

Wisp offers both brand-name prescriptions and a compounded sublingual option. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug; brand-name Zepbound is the exact molecule studied in the pivotal trials, though its actual pharmacy cost isn't disclosed by Wisp. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Wisp's real strengths: a genuinely verified LegitScript seal, plus named board-certified providers and unusual candor about the sublingual option's limits. The trade-offs is the $99/month headline doesn't include the actual medication cost for brand prescriptions, the compounded sublingual option is self-described as less effective than injection, and brand-name pharmacy pricing is outside anything Wisp quotes. As with any GLP-1 program, and especially one whose headline price excludes the medication itself, get a full quote including your specific pharmacy's price before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Wisp's genuinely verified LegitScript seal and named clinicians are real strengths this review confirmed directly, but its $99/month headline excludes the actual brand-name medication cost — get a full quote before assuming that's your total price. For a provider with a fully all-in published price, compare it against Vitara RX or Vytora Health. See our best tirzepatide providers ranking for the full field.